Ferdinand Althammer is a postdoctoral researcher in Christian Schaaf’s lab at the University of Heidelburg in Germany.
Ferdinand Althammer
Postdoctoral researcher
University of Heidelberg
From this contributor
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
By
Peter Hess
7 September 2022 | 4 min read
Explore more from The Transmitter
Everything everywhere all at once: Decision-making signals engage entire brain
The findings, gleaned from the most comprehensive map yet of brain activity during decision-making in mice, show that the process is even more distributed than previously thought.
Everything everywhere all at once: Decision-making signals engage entire brain
The findings, gleaned from the most comprehensive map yet of brain activity during decision-making in mice, show that the process is even more distributed than previously thought.
By
Claudia López Lloreda
3 September 2025 | 5 min read
Astrocyte networks span large swaths of brain
The networks are plastic, connect brain regions that aren’t connected by neurons and may enable long-distance communication between astrocytes, a new preprint shows.
Astrocyte networks span large swaths of brain
The networks are plastic, connect brain regions that aren’t connected by neurons and may enable long-distance communication between astrocytes, a new preprint shows.
By
Calli McMurray
3 September 2025 | 5 min listen
New findings on Phelan-McDermid syndrome; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 September.
New findings on Phelan-McDermid syndrome; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 September.
By
Jill Adams
2 September 2025 | 2 min read